Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International multicenter open-label treatment-extension study of SAR245408 and SAR245409
2011-006140-78Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pilaralisib and voxtalisib in cancer, sponsored by Sanofi. Primary endpoint: Safety and tolerability. Started Feb 2012; status: completed.
02
Drugs
pilaralisibvoxtalisib
03
Conditions
cancer
Beyond the preview
Go deeper on 2011-006140-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006140-78.